Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark
Clinical Snapshot
PICO Framework
| P — Population | Patients with arrhythmia, heart failure, or ischaemic heart disease with HADS-A scores ≥8 |
| I — Intervention | Structured Clinical Interview for DSM (SCID) assessment |
| C — Comparator | HADS-A screening tool |
| O — Outcomes | Prevalence and types of anxiety disorders confirmed by SCID diagnostic criteria |
Bottom Line
This Danish study validates HADS-A screening in cardiac patients, finding that 84% of those scoring ≥8 meet formal anxiety disorder criteria. Among 7816 cardiac patients screened, 23% had elevated anxiety scores, with generalised anxiety disorder (61%) and panic disorder (23%) being most common. While the high positive predictive value supports routine HADS-A screening in cardiology practice, the study's major limitation is selection bias - only 22% of eligible patients consented to diagnostic interviews. The findings support systematic anxiety screening in cardiac populations, but clinicians should be aware that the true prevalence may differ from these volunteer-based estimates. The results align with established links between cardiac disease and anxiety, reinforcing the need for integrated cardiac-psychiatric care approaches in Australian practice.
Key Findings
P Value: Not reported for primary outcome
Effect Size: Positive predictive value of 84% for HADS-A screening
Primary Outcome: 84% of patients with HADS-A ≥8 met SCID criteria for anxiety disorder
Nnt Or Sensitivity: Sensitivity cannot be calculated without false negative data
Confidence Interval: Not reported
Clinical Application
HADS-A is brief, validated, and easily implemented in routine cardiac care Relevant to Australian cardiology practice; HADS widely used; supports RACGP guidelines on mental health screening in chronic disease Patients with cardiac conditions (arrhythmia, heart failure, ischaemic heart disease) in cardiology and primary care settings
Abstract
OBJECTIVES: To identify whether patients with arrhythmia, heart failure or ischaemic heart disease presenting with anxiety symptoms measured by the Hospital Anxiety and Depression Scale (HADS) have identifiable anxiety according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID) and, if so, which type of anxiety disorder based on the SCID. DESIGN: Initial screening data from the Heart and Mind randomised clinical trial. SETTING: Patients with arrhythmia, heart failure or ischaemic heart disease were screened using HADS, and patients with a HADS-anxiety (HADS-A) score≥8 were invited to participate. Participants were interviewed by trained cardiac nurses using the SCID to determine whether they met the criteria for anxiety and, if so, the type of anxiety disorder. RESULTS: Of the 7816 patients who completed the HADS questionnaire, 1803 (23%) had a HADS-A score≥8. Among these, 398 (22%) agreed to the SCID interview, and 336 (84%) met the diagnostic criteria for an anxiety disorder. The mean age was 61 years, with 40% being female. The mean HADS-A score was 11.3 (SD=2.7). The most common types of anxiety were generalised anxiety disorder (61%), panic disorder (23%) and specific phobia (8%). CONCLUSIONS: The majority of individuals identified by the instrument also met the diagnostic criteria for an anxiety disorder. Generalised anxiety disorder and panic disorder were the most prevalent subtypes. Anxiety was common across the cardiac population, underscoring the need for routine assessment and targeted intervention in clinical practice. TRIAL REGISTRATION NUMBER: NCT04582734.
References
- 1.Berg, S. K., Rasmussen, L. R., Thorup, C. B., Rasmussen, T. B., Christensen, A. V., Hammer, C. B., Jorgensen, M. B., Svendsen, J. H., Risom, S. S., Juul, C., & Schjødt, I. (2026). Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark. BMJ Open. https://doi.org/10.1136/bmjopen-2025-113682
Related Research
Bioelectrochemistry (Amsterdam, Netherlands)
From data to diagnosis: A comprehensive review of machine learning-driven wearable sensors in healthcare.
2 Aug 2026
Ultrasound in medicine & biology
A Systematic Review: The Application of Attention Mechanisms in Medical Ultrasound Image Processing
2 Aug 2026
Journal of the American Medical Informatics Association : JAMIA
Explainable machine learning in healthcare: methods, interpretation, and applications for clinical research
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service